AzTrials
AzTrials

Endometrial CancerNCT06307886

Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator

An observational study of Endometrial Cancer, run by Gaziosmanpasa Research and Education Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

Comparison of five-year survival and disease-free survival in patients diagnosed with endometrium cancer who underwent total laparoscopic hysterectomy with and without a uterine manipulator Read more about this study

Who is it for?
Ages 18 to 75 years, women only
Conditions the study is for
Endometrial Cancer
What is being tested?
Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With manipulator and lPatients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy without uterine manipulator
Type of treatment
Surgery or procedure
How many people
108 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2023to 1 Sep 2028
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • Women only
  • Adult, Older adult

Study population: Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator

Who may be able to join

  • patients suitable for laparoscopic surgery patients ages 18-75 patients diagnosed figo stage 1 and 2 endometrial cancer

Who cannot join

  • patients not suitable for laparoscopic surgery patients diagnosed figo stage 3 and 4 endometrial cancer pregnant patients

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Süleyman Salman, Professor contact

+905059345470

sleymansalman@gmail.com

havva betül bacak, Specialist contact

+905333610088

hbbacak90@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Gaziosmanpasa Training and research hospital

    Istanbul

    Süleyman Salman, Professor, +905059345470, sleymansalman@gmail.com

    Havva Betül Bacak, Specialist, +905333610088, hbbacak90@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Comparison of five-year survival and disease-free survival in patients diagnosed with endometrium cancer who underwent total laparoscopic hysterectomy with and without a uterine manipulator

Being tested
Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With manipulator, lPatients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy without uterine manipulator
Medical subject headings
Endometrial Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With manipulatorProcedure or surgery

    patients who underwent laparoscopic hysterectomy with using uterine manipulator

  • lPatients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy without uterine manipulatorProcedure or surgery

    patients who underwent laparoscopic hysterectomy without using uterine manipulator

Study groups in NCT06307886
Study groupRoleWhat they receive
patients diagnosed with endometrium cancerNot described
Receives: Procedure: Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With manipulator; Procedure: lPatients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy without uterine manipulator

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. five year survival in patients diagnosed with endometrial cancer

    Measured: 5 year

  2. disease-free survival in patients diagnosed with endometrial cancer

    Measured: 5 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2024
  2. Study start1 Sep 2023
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion1 Sep 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
108 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06307886
Sponsor's protocol ID
GaziosmanpasaTREHSs
Status last verified
Dec 2024
First submitted
6 Mar 2024
Last updated
7 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in